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ABSTRACT 81 
Background: Experts suggest that formulary alerts at the time of medication order entry is the 82 
most effective form of clinical decision support to automate formulary management.   83 
Objective: Our objectives were to quantify the frequency of inappropriate non-formulary 84 
medication (NFM) alert overrides in the inpatient setting and provide insight on how the design 85 
of formulary alerts could be improved.  86 
Methods: Alert overrides of the top 11 (n=206) most utilized and highest costing NFMs, from 87 
January 1st to December 31st, 2012, were randomly selected for appropriateness evaluation. 88 
Using an empirically developed appropriateness algorithm, appropriateness of NFM alert 89 
overrides were assessed by two pharmacists via chart review. Appropriateness agreement of 90 
overrides was assessed with a Cohen’s kappa. We also assessed which types of NFMs were 91 
most likely to be inappropriately overridden, the override reasons which were 92 
disproportionately provided in the inappropriate overrides, and the specific reasons why the 93 
overrides were considered inappropriate. 94 
Results: Approximately 17.2% (n=35.4/206) of NFM alerts were inappropriately overridden. 95 
Non-oral NFM alerts were more likely to be inappropriately overridden compared to orals. 96 
Alerts overridden with ‘blank’ reasons were more likely to be inappropriate. The failure to first 97 
try a formulary alternative was the most common reason for alerts being overridden 98 
inappropriately.  99 
Conclusion: Approximately one in five NFM alert overrides are overridden inappropriately. 100 
Future research should evaluate the impact of mandating a valid override reason and adding a 101 
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list of formulary alternatives to each NFM alert, we speculate these NFM alert features may 102 
possibly decrease the frequency of inappropriate overrides.  103 
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INTRODUCTION 104 
A hospital formulary is a continuously updated list of medications that represents the 105 
current clinical perspective of hospital healthcare providers for the care of admitted 106 
patients.[1] Medications on this list are generally viewed as cost-effective compared to their 107 
non-formulary alternatives, also termed non-formulary medications (NFMs). Typically, NFMs 108 
are not stocked and require special order entry and procurement procedures by the prescriber 109 
and pharmacy prior to use. These special order entry and procurement procedures can increase 110 
labor costs ($15.94 to $23.34 per order)[2-4] and can substantially delay NFM initiation (10.6 111 
hours).[3] NFMs are also more error prone than formulary alternatives, where NFMs and their 112 
directions are more likely to be unfamiliar to hospital staff and may be misinterpreted.[5-8]  113 
However, the need for hospitals to provide NFMs is unavoidable. Often admitted patients 114 
are stabilized on a pre-admission, chronic NFM and substitution with a formulary alternative 115 
could put the patient at risk for harm (i.e. antipsychotics and antiepileptics). Experts suggest 116 
pop-up alerts containing a list of formulary alternatives is the most effective clinical decision 117 
support (CDS) design to automate NFM management and limit the ill-effects of formulary non-118 
compliance.[9]  119 
Empiric verification to support this suggestion is limited. Analogous evidence can be drawn 120 
from the more commonly used computerized alerts (drug-allergy, drug-drug interactions, drug-121 
disease contraindication, etc.), where studies have shown these alerts improve prescribing 122 
behaviors, reduce prescribing errors, impact clinical outcomes, and decrease medication 123 
cost.[10] However, these benefits are attenuate with high alert overrides frequencies (49-124 
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96%).[11] Therefore, we are unsure if the aforementioned alert benefits are generalizable to 125 
formulary alerts. 126 
To our knowledge, there are no studies evaluating the appropriateness of NFM alert 127 
overrides. We suspect this gap in the literature is likely due to the large variation in formularies 128 
and NFM policies from institution to institution and the resources required to create NFM alert 129 
specific appropriateness criterions for each medication not on formulary. Thus, we previously 130 
developed a ‘general’ appropriateness algorithm that institutions could adapt to evaluate the 131 
appropriateness of their NFM alert overrides.[12] We adapted this general algorithm to our 132 
institution’s NFM use guidelines and evaluated the inappropriateness of a random sample of 133 
NFM alert overrides.  134 
METHODS 135 
Setting 136 
Brigham and Women’s Hospital (BWH) is a 793-bed academic medical center in Boston, 137 
MA that admits approximately 46,000 patients annually for a full range of inpatient services, 138 
with the exception of pediatrics. Both formulary and non-formulary medications are available 139 
for patient care through a computerized provider order entry (CPOE) system. Full details of 140 
BWH’s CPOE system are described elsewhere.[13] Formulary alerts embedded in the CPOE 141 
system are used to automate formulary management. Upon order entry of a NFM, prescribers 142 
are informed of its non-formulary status with three types of pop-up alerts: 1) a ‘soft stop’ 143 
requesting the input of a free-texted override reasons, explaining the rationale of formulary 144 
deviation, 2) an ‘intermediate stop’ requesting a free-texted override reason and identifying the 145 
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specialist physician who approved the NFM for use, and 3) a ‘hard stop’ stating the NFM is not 146 
available for use and prompting the prescriber to order the preferred alternative (Figure 1 and 147 
2). 148 
  
 
Figure 1: Non-formulary medication alerts at Brigham and Women’s Hospital 
Modified from Her et al, 2015[12] 
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C. 
 
Figure 2: Non-formulary pop-up alerts 
 A) Soft stop, B) Intermediate stop, and C) Hard stop  
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Study Design and Sampling of NFM alert overrides 149 
This observational study was conducted on all NFM alerts overridden from January 1st to 150 
December 31st, 2012. These overrides and their relevant data elements were extracted from 151 
Brigham Integrated Computer System (BICS) and loaded into a Microsoft Access Database 152 
(Microsoft Corp, Redmond, WA). Relevant data elements included patient’s medical record 153 
number, patient name, admission date, discharge date, NFM order entry date, NFM order entry 154 
time, medication unique identifier, generic medication name, route, dosage, dosing frequency, 155 
prescriber name, and the free-texted NFM alert override reason.   156 
We limited our sample of NFM alert overrides to original overrides and excluded 157 
overrides that were the result of medication dose, direction, or frequency changes. The latter 158 
overrides’ rational for formulary deviation were the same as the original and including them 159 
into our evaluation would duplicate alerts. Further, at BWH there are two sources of non-160 
formulary designation, one in BICS and the other in an online formulary dictionary. Our internal 161 
study found inconsistencies in these two sources. To ensure our evaluation included only true 162 
NFMs, we further limited our overrides sample to medications listed as non-formulary in both 163 
sources. 164 
Total medication cost, composed of procurement and medication cost from 2009 to 165 
2012, were computed for each NFM. The average procurement cost of providing a NFM over 166 
formulary alternatives was estimated to be $20.07 per order.[2] This estimate was used to 167 
convert the number of NFM orders to a monetary value. Medication costs were estimated from 168 
a BWH’s medication wholesaler account during the first quarter of 2014. NFMs were ranked 169 
from highest to lowest total cost, and twenty alert overrides were randomly selected from the 170 
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top 11 NFMs for override appropriateness evaluation. Figure 3 describes our NFM alert 171 
override sampling scheme.  172 
 173 
NFM alert override appropriateness criteria  174 
Previously, we empirically developed a general NFM alert override appropriateness 175 
algorithm from free-texted NFM alert override reasons. Full details of the methodology and 176 
2012 NFM Alert 
Overrides 
N = 71,145 
Original NFM Alert 
Overrides 
N = 59,102 
NFM Alert Overrides 
N = 206
ɣ
 
Random selection of 20 alert overrides 
Top 11 NFMs’ 
Alert Overrides  
N = 11,918
		
 
Figure 3: NFM alert override random selection  
	
Top 11 most approved and highest costing NFMs 
ɣ
In 2012 there were only six alert overrides for liposomal doxorubicin  
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performance of the algorithm can be found elsewhere.[12] In brief, a NFM alert override reason 177 
categorization scheme was created from a random sample of 5,000 overrides according to 178 
keywords, context, and value explaining the rationale for formulary deviation. An initial 179 
appropriateness algorithm was developed from these override reason categories and presented 180 
to an interdisciplinary team of healthcare providers to evaluate clinical creditability and provide 181 
feedback. BWH pharmacists were also consulted and the algorithm was simplified to an eight 182 
question general appropriateness algorithm (Figure 4). Available BWH medication monographs, 183 
treatment guidelines and medication administration guidelines of the top 11 NFMs were 184 
ascertained from the BWH Pharmacy intranet website and incorporated into the general 185 
algorithm to create insitution specific NFM alert override algorithms.  186 
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Figure 4: General NFM alert override appropriateness algorithm 
Modified from Her et al, 2015[12] 
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Chart review and appropriateness evaluation 187 
All inpatient notes corresponding to the hospitalization when the NFM alert was 188 
overridden were downloaded from BICS. A hyperlink to this document was created in the 189 
Microsoft Access Database to facilitate reviewer access. All medication orders and medication 190 
administration logs during hospitalization were available through BICS. Outpatient medication 191 
records were available through BWH’s ambulatory care electronic medical record, Longitudinal 192 
Medical Record (LMR).  193 
Two pharmacists (QLH and MGA) assessed the appropriateness of each NFM alert 194 
override according to the general appropriateness algorithm or NFM specific appropriateness 195 
algorithms via in-depth chart review. They first reviewed the override reason explaining the 196 
formulary deviation and identified ‘preliminary’ formulary alternatives to the NFM. Second, the 197 
pharmacists ensured that the NFM was not contraindicated and could not potentially induce 198 
harm to the patient according to the information found in the inpatient notes (i.e. chief 199 
complaint of admission, medical history, allergies, or drug interactions). If the NFM posed any 200 
potential harm to the patient, the NFM alert override was considered inappropriate. The 201 
reviewers also reviewed medication orders and medication administration logs for evidence of 202 
having previously tried formulary alternatives prior to the NFM alert override. The NFM alert 203 
override was considered appropriate if a formulary alternative was first tried or there was an 204 
explanation provided in the inpatient notes as to why a formulary alternative was not 205 
considered an option, otherwise the NFM alert override was considered inappropriate. 206 
NFM alerts with ‘blank’ or marginal value reasons (explaining formulary deviation) were 207 
deemed inappropriate unless an appropriate justification (specialist consult, pharmacological 208 
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interaction, active disease that required the medication etc) for the NFM was discovered during 209 
chart review. NFM alert overrides justified with syntax variants of the NFM being a pre-210 
admission or home medication were considered appropriate only if the NFM was found 211 
documented as a current medication in LMR during the dates of hospitalization or was listed in 212 
the admission history and physical note as a medication taken prior to admission. For NFMs 213 
justified by a ‘disease or condition’ reason, the literature was searched to ensure minimal 214 
supporting evidence existed (i.e. at least a case-report) for the proposed indication. If any 215 
evidence was found in the literature and the listed ‘disease or condition’ was found in the 216 
inpatient notes, then these overrides were deemed appropriate. Remaining potential reasons 217 
included specialist or pharmacist recommendation, therapeutic failure or intolerance to 218 
formulary alternatives, pharmacological reasons, end of life care, and drug shortages. These 219 
NFM alert overrides were appropriate as long as documented evidence was found in the 220 
inpatient notes. For example, olanzapine was often justified with ‘per psych recommendation,’ 221 
this NFM alert override would be considered appropriate if a psychiatrist consult 222 
recommending the medication was found in the inpatient notes prior the NFM being ordered. 223 
In addition, NFMs with BWH specific NFM use guidelines were considered appropriate only if 224 
they were used within those criteria.  Disagreements between pharmacists were resolved by 225 
discussion with a third reviewer (DLS). 226 
Outcomes and objectives 227 
Our primary objective was to quantify the frequency of NFM alerts overridden 228 
inappropriately in the top 11 NFMs. Our secondary objectives were to identify which (1) types 229 
of NFMs (oral and non-oral) were most likely to be inappropriately overridden, (2) override 230 
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reasons disproportionately represent inappropriate NFM alert overrides, and (3) specific 231 
reasons why the NFM alert override was considered inappropriate. A post-hoc analysis was 232 
conducted to identify the frequency of override reason given in the NFM alert pop-up not 233 
congruent to the formulary deviation reason documented in the inpatient notes; we term these 234 
discrepancies as discordant alert override reasons. 235 
Statistical Analysis 236 
Counts and frequencies were used to summarize the number of inappropriate overrides 237 
according to NFM and our empirically developed NFM alert override reason categorization 238 
scheme.[12] To make overall inferences about the top 11 NFM alert overrides from our 239 
stratified random sample, post-stratification weights were computed and applied to the counts 240 
and frequencies. Weights for primary objective and secondary objective 1 were the quotients of 241 
the proportion of NFM alert overrides in the top 11 NFM alert overrides and the proportion of 242 
the NFM’s alert overrides in our sample.  243 
Post-stratification weights for secondary objective 2 were computed from our 244 
experience with an ongoing study of override reasons predictors. In brief, a random sample of 245 
10,000 NFM (2009-12) alert overrides were extracted from BICS and their reasons were 246 
categorized according to the aforementioned reason categorization scheme by two pharmacist 247 
and a physician. Agreement in the override reason categorization between the reviewers was 248 
found to be high (ҡ=0.86). For the present study, we excluded all non-top 11 NFM alert 249 
overrides and the remaining constituted our auxiliary data for post-stratification weight 250 
computation. Specifically, these weights were the quotient of the proportion of override 251 
reasons in the auxiliary data and the proportion of NFM alert override reasons in our sample of 252 
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overrides (calculations are available in the online supplementary). All statistical inferences 253 
were conducted on these weighted counts and frequencies. 254 
Agreement in the inappropriateness of NFM alert overrides between the two pharmacists was 255 
evaluated with a Cohen’s kappa. A chi-square test was used to compare the distribution of 256 
inappropriate NFM alert overrides among oral and non-oral NFMs.  A chi-square test was also 257 
first used to determine if inappropriate NFM alert overrides were disproportionately 258 
distributed among the override reasons categories. If this latter test was found to be statistical 259 
significant, the frequency of inappropriate overrides in each override reason category was 260 
compared to the frequency of the alert override reason in our sample using a student t-test. P-261 
values of less than 0.05 was considered to be statistically significant. A Bonferroni correction 262 
was applied to the student t-test to adjust for multiple testing. All statistical analyses were 263 
conducted using SAS software (version 9.4 SAS Institute, Cary, NC). This study was approved by 264 
the Partners Human Research Committee. 265 
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RESULTS 266 
Table 1 
   Unweighted Weighted 
Top 11 Most 
Approved and 
Highest Costing 
NFMs   
No. of 
NFM 
Alert 
Overrides 
Inappropriate 
NFM Alert 
Overrides 
Frequency of 
Inappropriate 
NFM Alert 
Override 
No. of NFM 
Alert 
Overrides 
Proportion of 
NFM Alert 
Overrides 
No. of 
Inappropriate 
NFM Alert 
Overrides 
Frequency of 
Total 
Inappropriate 
Alert Overrides  
Oral non-formulary medications (n=80, 38.8%) 
Aprepitant (PO) 20 0 0.0% 7.83 
60.1% (n= 123.8) 
0.00 
42.8% (n= 15.18) 
Olanzapine (PO) 20 0 0.0% 19.36 0.00 
Olanzapine ODT (PO) 20 1 5.0% 27.66 1.38 
Quetiapine (PO) 20 4 20.0% 68.98 13.80 
Non-oral non-formulary medications (n= 126, 61.2%) 
Dornase Alfa (Neb) 20 4 20.0% 6.22 
39.9% (n= 82.2) 
1.24 
57.2% (n= 20.26) 
Liposomal 
Doxorubicin (IV) 6 
0 0.0% 0.10 0.00 
Metronidazole 1% 
(Cream) 20 
6 30.0% 0.76 0.23 
Mometasone Furoate 
(Inhaler) 20 
4 20.0% 3.34 0.67 
Ranitidine (IV) 20 16 80.0% 19.48 15.58 
Rasburicase (IV) 20 0 0.0% 1.49 0.00 
Scopolamine (Patch) 20 1 5.0% 50.78 2.54 
Total 206 36 17.5% 206 100% (n= 206) 35.4 (17.2%)   
 267 
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In 2012, 71,145 NFM alerts were overridden, of which 59,102 were original alert 268 
overrides for 45,352 hospitalizations. Thus, about 1.3 original NFM alerts were overridden with 269 
each hospitalization. The 11 most approved and highest costing NFMs can be found in Table 1. 270 
Four NFMs were oral medications, of which three were atypical antipsychotics. The remaining 271 
seven included three intravenous medications, two inhalants, and two topicals. The stratified 272 
random sample selected 206 NFM alerts overrides from these medications (there were only six 273 
liposomal doxorubicin overrides in 2012), which were prescribed by 174 distinct health care 274 
providers: 150 physicians, 21 physician-assistants, and three pharmacists.  275 
Two (rasburicase and dornase alfa) of the 11 NFMs in our study had specific medication 276 
administration guidelines that contain ‘major use’ indications. Another two NFMs (scopolamine 277 
patches and aprepitant) were found in the institutions Guidelines for Assessment and 278 
Management of Nausea and Vomiting. With input from the interdisciplinary healthcare team, 279 
NFM specific criterions were created for these four NFMs (available in online supplementary).  280 
According to the appropriateness algorithms, the two pharmacists found 17.2% (n=35.4) 281 
of the top 11 NFM alerts overridden inappropriately (Table 1). Agreement between reviewers 282 
was high, κ=0.97 (95% CI: 0.92 – 1.00). Inappropriate alert overrides were disproportionately 283 
distributed in non-oral NFMs (p=0.021), where 57.2% (n=20.3) of inappropriate alert overrides 284 
were non-oral NFMs, but constituted only 39.9% (n=82.2) of the alert override sample (Table 285 
1). 286 
  287 
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Table 2: Non-Formulary Medication Alert Override Appropriateness Evaluation 
Initiate Non-Formulary Override Reason 
Classification 
Unweighted
1
 Weighted 
Total No. 
Overrides (% of 
Total) 
Total No. 
Overrides  (% 
of Total) 
Appropriate 
(% of 
Appropriate) 
Inappropriate 
(% of 
Inappropriate) 
P-Value
2
 
Blank 51 (24.8%) 44.5 (21.6%) 27.1 (15.7%) 17.5 (51.4%) 0.0002 
Disease or Condition Listed 64 (31.1%) 68.1 (33.1%) 63.8 (37.1%) 4.3 (12.5%) 0.0005 
Home or Pre-Admission Medication 38 (18.4%) 34 (16.5%) 29.5 (17.1%) 4.5 (13.1%) 0.5687 
Home Medication 38 (18.4%) 33.8 (16.4%) 29.3 (17%) 4.4 (13.1%)   
Marginal Value for NF Decision:  30 (14.6%) 37.1 (18%) 32.2 (18.7%) 5 (14.6%) 0.5685 
Acknowledge NF status 2 (1%) 3.3 (1.6%) 3.3 (1.9%) 0 (0%)   
Content Free 1 (0.5%) 0.9 (0.4%) 0.9 (0.5%) 0 (0%)   
MD/Attending/Team Request, Prefers NF Medication 11 (5.3%) 10.7 (5.2%) 7.8 (4.5%) 2.9 (8.6%)   
MisCommunication: Medication use direction 3 (1.5%) 1.4 (0.7%) 1.4 (0.8%) 0 (0%)   
Others 2 (1%) 2.9 (1.4%) 2.9 (1.7%) 0 (0%)   
Patient Preference/Request 2 (1%) 0.9 (0.4%) 0.9 (0.5%) 0 (0%)   
Reason Listed "Appropriate, Effective, Indicated, Medical 
Necessity, No Alternative 
1 (0.5%) 3.4 (1.6%) 3.4 (2%) 0 (0%)   
Reason Listed "Need*/Requir* OR Patient Need*/Require* 8 (3.9%) 11.3 (5.5%) 9.9 (5.7%) 1.4 (4.2%)   
Pharmacological Reason:  4 (1.9%) 3.5 (1.7%) 2.6 (1.5%) 0.9 (2.6%) 0.6675 
Contraindication 1 (0.5%) 0.1 (0%) 0.1 (0.1%) 0 (0%)   
Drug Route Conflict 1 (0.5%) 2.4 (1.2%) 0 (0%) 2.4 (7.1%)   
Others 2 (1%) 0.8 (0.4%) 0.8 (0.5%) 0 (0%)   
Specialist Recommendation 10 (4.9%) 10.9 (5.3%) 9.8 (5.7%) 1.1 (3.2%) 0.4753 
Physician Specialist / Other Service 10 (4.9%) 10.6 (5.1%) 9.5 (5.5%) 1.1 (3.1%)   
Therapeutic Failure / Intolerant to formulary 
alternatives:  
9 (4.4%) 7.9 (3.8%) 7 (4.1%) 0.9 (2.6%) 
0.6796 
Medication Listed 6 (2.9%) 3.1 (1.5%) 3.1 (1.8%) 0 (0%)   
Unspecified or Medication Not Listed 3 (1.5%) 3.2 (1.6%) 2.1 (1.2%) 1.1 (3.1%)   
Total 206 206 172.02 33.98  
1
Unweighted data and post-stratification weight computation are available in the online supplementary. 
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2
P-values less than 0.007 (=0.05/7) were considered statistically significant, after application of a Bonferroni correction to the  
comparison of the proportions of inappropriate alert overrides to the proportion of overrides in each override reason category.    
 288 
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There were 117 unique override reasons in the 206 NFM alert override sample. These 289 
reasons were categorized into 17 of the 24 previously developed override reason categories 290 
(Table 2). The most common reason explaining formulary deviation of the top 11 NFMs was the 291 
provision of a ‘disease or condition’ (33.1%, n=68.1). No (‘blank,’ n=44.5) or marginal value 292 
reasons (n=37.1) were provided in 39.6% of the top 11 NFM alert overrides. ‘Home or Pre-293 
Admission Medications’ reasons were used to justify 16.5% (n=34) of alert overrides and clinical 294 
reasons of pharmacological, specialist recommendation, and failure or intolerance to formulary 295 
alternatives definition explained 10.8% (n=22.3) of the NFM alert overrides.  296 
A chi-square test confirmed a disproportionate distribution of inappropriate overrides 297 
among the categories of override reasons in our sample of alert overrides, p< 0.001. 298 
Specifically, subanalysis found 51.4% (n=17.5) of inappropriate overrides were nested in the 299 
‘blank’ override reason category, while ‘blanks’ only accounted for 21.6% of appropriate alert 300 
override reasons, p=0.0002. Contrary, 12.5% of inappropriate overrides were nested in the 301 
‘disease or condition’ reason category, while these reasons accounted for 33.1% of the reasons 302 
in our sample of the top NFM alert overrides, p=0.0001. Statistical analysis did not find a 303 
disproportionate number of inappropriate overrides in the remaining override reason 304 
categories (Table 2).   305 
Chart reviews identified 24 (66.7%) of the 36 inappropriate NFM alert overrides were 306 
the result of not trying formulary alternatives prior to the NFM (Table 3). Eight (22.2%) of the 307 
inappropriate NFM alert overrides were justified as a pre-admission or home medication, but 308 
no evidence of active outpatient prescription was found in the patient’s LMR. Chart reviews 309 
failed to find any information justifying the use of the NFMs in three (8.3%) inappropriate alert 310 
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overrides. These NFM alerts were overridden with a ‘blank’ or marginal value reasons 311 
(prescriber preference). Lastly, there was only one case where the NFM was deemed clinically 312 
inappropriate to the patient involving the use of an atypical antipsychotic to address dementia 313 
in an elderly patient, which has been linked to an adverse outcome.[14 15] Post-hoc analysis 314 
found ‘blank’ and marginal value reasons have the highest frequency of discordant override 315 
reasons, 94.1% an  93.3%, respectively (Table 4). 316 
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Table 3: Reasons explaining why the NFM alert override was considered inappropriate  
Non-Formulary Alert Override 
Reason Class 
Total 
Formulary 
alternative was 
not first trial 
prior to NFM 
alert override 
No citation or 
information 
could be found 
justifying 
formulary 
deviation during 
chart review 
Clinically 
Inappropriate 
No evidence 
of active 
home 
medication 
found in LMR 
No documentation 
of specialist 
recommendation 
during chart review 
Blank 20 17 1 0 2 0 
Disease or Condition Listed 4 4 0 0 0 0 
Home or Pre-Admission 
Medication 
5 0 0 0 5 0 
Marginal Value for NF Decision: 
MD/Attending/Team Request, 
Prefers NF Medication 
3 0 2 1 0 0 
Marginal Value for NF Decision: 
Reason Listed "Need*/Requir* OR 
Patient Need*/Require* 
1 0 0 0 1 0 
Pharmacological Reason: Drug 
Route Conflict 
1 0 0 0 0 1 
Specialist Recommendation 1 1 0 0 0 0 
Therapeutic Failure / Intolerant to 
formulary alternatives: 
[Unspecified or Medication Not 
Listed] 
1 1 0 0 0 0 
Total 36 23 (63.89%) 3 (8.33%) 1 (2.78%) 8 (22.22%) 1 (2.78%) 
  317 
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Table 4: Frequency of Discordant NFM Alert Override Reasons  
Initiate Non-Formulary 
Override Reason Classification 
Final NFM Override Reason Category (Post-Chart Review) 
Total 
Frequency 
of 
Discordant 
Reason for 
NFM Alert 
Override  
Blank 
Disease or 
Condition 
Listed 
Home or 
Pre-
Admission 
Medication 
Marginal Value for 
NF Decision: 
MD/Attending/Team 
Request, Prefers, NF 
Medication 
Pharmacological 
Reason: Drug 
Route Conflict 
Pharmacological 
Reason: Others 
Specialist 
Recommendation 
Therapeutic 
Failure / 
Intolerant 
to 
formulary 
alternatives: 
[Medication 
Listed] 
Blank 51 94.1% 3 42 3 0 0 0 0 3 
Disease or Condition Listed 64 7.8% 0 59 4 0 1 0 0 0 
Home or Pre-Admission 
Medication 
38 10.5% 0 1 34 0 0 0 3 0 
Marginal Value for NF 
Decision: 
30 93.3% 0 16 10 2 1 0 0 1 
MisCommunication: 
Medication use direction 
3 100.0% 0 2 1 0 0 0 0 0 
Acknowledge NF status 2 100.0% 0 1 1 0 0 0 0 0 
Content Free 1 100.0% 0 1 0 0 0 0 0 0 
MD/Attending/Team 
Request, Prefers NF Medication 
11 81.8% 0 7 2 2 0 0 0 0 
Others 2 100.0% 0 2 0 0 0 0 0 0 
Patient 
Preference/Request 
2 100.0% 0 0 1 0 1 0 0 0 
Reason Listed 
"Appropriate, Effective, 
Indicated, Medical Necessity, 
No Alternative 
1 100.0% 0 0 0 0 0 0 0 1 
Reason Listed 
"Need*/Requir* OR Patient 
Need*/Require* 
8 100.0% 0 3 5 0 0 0 0 0 
Pharmacological Reason:  4 50.0% 0 1 0 0 1 1 0 1 
Contraindication 1 100.0% 0 1 0 0 0 0 0 0 
Drug Route Conflict 1 0.0% 0 0 0 0 1 0 0 0 
Others 2 50.0% 0 0 0 0 0 1 0 1 
Specialist Recommendation: 
Specialist / Other Service 
Recommended 
10 20.0% 0 2 0 0 0 0 8 0 
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Therapeutic Failure / 
Intolerant to formulary 
alternatives:  
9 33.3% 0 1 0 0 0 0 0 8 
Medication Listed 6 0.0% 0 0 0 0 0 0 0 6 
Unspecified or Medication 
Not Listed 
3 33.3% 0 1 0 0 0 0 0 2 
Total 206   3 122 51 2 3 1 11 13 
  318 
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DISCUSSION 319 
Our observational study found approximately one-fifth of NFM alert overrides in our sample 320 
of the top 11 NFMs was inappropriately overridden. Alerts of non-oral NFMs compared to oral 321 
NFMs were more likely to be inappropriately overridden. We also found NFM alerts overridden 322 
with no reason (‘blank’) were more likely to be inappropriately overridden, while those with 323 
‘disease or condition’ reasons were less likely to be inappropriately overridden. In-depth chart 324 
review found the failure to first try a formulary alternative was the most common reason for a 325 
NFM alert override to be inappropriate. Lastly, NFM alerts overridden with ‘blank’ or ‘marginal 326 
value’ reasons often had justifiable formulary deviation reasons in the medical notes, but were 327 
poorly documented in the NFM alert pop-up interface.  328 
To our knowledge there are no studies evaluating the appropriateness of NFM alert 329 
overrides. Thus, we are unsure of how our findings compared to other institutions. An 330 
evaluation of the appropriateness of NFM alert overrides is inherently evaluating the 331 
appropriate use of NFM. Therefore, inappropriate NFM usage frequencies may provide some 332 
estimation of the frequency of inappropriate NFM alerts overrides.  333 
Available studies suggest the frequency of inappropriate NFM usage is approximately 60% 334 
to 70%. Specifically, a small 6-week prospective study at an academic medical center found 61% 335 
of NFM dispensed failed to comply to institution criteria[8] and a study evaluating the impact of 336 
a comprehensive formulary management system from a non structured system decreased NFM 337 
utilization from 17.8 to 5.9 medications per 100 admissions. This suggests an upper 67% bound 338 
of inappropriate NFM use.[2] Our lower frequency is likely attributed to BWH’s ‘relaxed’ 339 
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formulary and our sample was composed of NFMs previously approved by pharmacist for use, 340 
hence also decreasing the number of inappropriate alert overrides.  341 
Formulary Alert Design Insights 342 
The literature on formulary CDS is scarce. Our secondary findings provide important 343 
perspectives on how to prioritize and possibly improve the design of alerts for automated 344 
formulary management.  First, alert improvement and optimization should be a prioritize to 345 
non-oral NFMs. Non-oral NFMs have greater cost-implications than oral NFMs. Sweet et al 346 
estimated the successful conversion of non-oral NFMs to a formulary alternative saves between 347 
$7.04 to $94.60 compared to only $16.62 in oral NFMs.[4] Our study found non-oral NFM alert 348 
overrides were more likely to be inappropriate compared to oral NFMs. Thus, optimization of 349 
automated formulary management with non-oral NFMs is more likely to yield formulary cost-350 
savings. 351 
Second, it is not surprising that the provision of no reason (‘blank’) to NFM alerts overrides 352 
were disproportionately inappropriate. This is to be likely reflective of BWH’s ‘relaxed’ 353 
formulary, but also a characteristic of volunteer free-texted alert systems.[16] Mandating the 354 
provision of an override reason may decrease the frequency of inappropriate NFM alert 355 
overrides, hence inappropriate NFM use. 356 
Third, we expected the NFM alerts overridden with clinical reasons (pharmacological, 357 
specialist recommendation, and therapeutic failure / intolerant to formulary alternatives) more 358 
likely to be appropriate, but were only able to demonstrate this relationship with alerts 359 
overridden with ‘disease or condition’ reasons. The inability to demonstrate this hypothesis 360 
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with the former clinical reasons is likely due to their small numbers in our sample. Our previous 361 
study found clinical reasons were rarely entered into our alert system,[12] which is surprising 362 
with our sampling being composed of only approved NFM overrides. Post-hoc analysis and 363 
chart review found nearly all NFM alerts overridden with ‘blank’ (45 of the 51) or ‘marginal 364 
value’ (28 of the 30) reasons could have been overridden with clinical reasons (Table 4). Our 365 
chart review foun  a large number of these overrides contained ‘disease or condition’ rationale 366 
for NFM usage (58 of the 81) and appropriate (57 of the 81), but justification was poorly 367 
documented in the NFM alert pop-up window. This is consistent with our findings that NFM 368 
alerts overridden with ‘disease or condition’ reasons are likely to be appropriate. Thus, we 369 
speculate mandating the provision of a valid override reason may possibly shift the behavior of 370 
providing of ‘blank’ and ‘marginal value’ reasons to ‘disease or condition’ reasons, hence 371 
possibly decreasing the frequency of inappropriate NFM alert overrides.  372 
Fourth, chart review found inappropriate NFM alert overrides were largely attributed to 373 
prescriber not trying formulary alternatives prior to the NFM. This is likely to be due to BWH’s 374 
large number of NFMs managed by a soft stop, where guidance to formulary alternatives is not 375 
provided. Listing formulary alternatives in the pop-up alerts may facilitate the use and trial of 376 
formulary alternatives, hence decreasing the frequency of inappropriate NFM alert overrides. A 377 
recent study found an obtrusive, hard-stop, pop-up alert prompting formulary interchange 378 
decreased formulary non-adherence by 65%.[17] In addition a list of formulary alternatives that 379 
is clear, concise, and includes links to additional information may also further decrease the 380 
frequency of inappropriate NFM alert overrides.[11 18-20]   381 
Limitations 382 
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Our study has a number of limitations. First, our study was retrospective, thus we were 383 
limited to the information documented in the inpatient notes and administrative data. There 384 
were three ‘blank’ overrides where no information regarding the rationale of NFM use was 385 
found and numerous incidences where ‘blank’ overrides were actually justified after chart 386 
review. This leads us to infer that prescribers could have discussed appropriate rationale for 387 
NFM alert overrides during patient care rounds with the team, specialist, or rounding 388 
pharmacist, but failed to document appropriately. Therefore, the aforementioned three ‘blank’ 389 
overrides may have been appropriate, but just not appropriately documented, decreasing our 390 
frequency of inappropriate override to 16.0%.  391 
Second, our study was undertaken at a single medical center with an in-house 392 
developed CPOE system and utilized appropriateness criteria specific to one institution. Thus 393 
the quantitative results may not be fully generalizable to other institutions and medication 394 
ordering system. Nevertheless, our study provide important design perspectives on 395 
computerized formulary management systems and formulary-based alerts, which may be 396 
considered to further ensure formulary cost-savings, quality of care, and medication safety. In 397 
addition, with the application of empirically developed general appropriateness criteria to an 398 
automated formulary management system our study may serve as a model for future 399 
formulary-based CDS studies.  400 
Lastly, our analysis focused on only a subset of NFM alert overrides, the most approved 401 
and highest costing NFMs. It is possible our findings may have differed with the inclusion of all 402 
NFMs. However, such a study is likely infeasible due to the need to create alert override 403 
appropriateness criteria for each NFM. Our decision to focus on the highest cost and most 404 
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approved NFMs was to identify insight that may yield the greatest improvement in the use of 405 
alerts for formulary management. 406 
CONCLUSION 407 
To our knowledge, our study is the first to empirically evaluate the appropriateness of 408 
NFM alerts overrides in the inpatient setting. This is a labor-intensive task and requires the 409 
creation of appropriateness criteria for each NFM. We circumvented this issue by tailoring an 410 
empirically developed NFM alert override general appropriateness algorithm to our institution’s 411 
NFM use guidelines and focused on the most approved and high costing NFMs. This study 412 
conservatively estimated that one in five NFM alert overrides were inappropriately overridden. 413 
Future research should evaluate the impact of mandating a valid override reason and adding a 414 
list of formulary alternatives to each NFM alert, we speculate these NFM alert features may 415 
possibly decrease the frequency of inappropriate NFM alert overrides, especially in those 416 
overridden with a ‘blank’ or ‘marginal value’ reason.  417 
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Table 1 
  Unweighted   Post-Stratification Weight Computations  
Top 11 Most 
Approved and Highest 
Costing NFMs   
No. of 
NFM Alert 
Overrides 
Inappropriate 
NFM Alert 
Overrides 
Alert 
Override 
Population  
(N = 11,918) 
Proportion of 
Alert Override 
Population  
Proportion of 
Alert Override 
Sample  
Post-
Stratification 
Weights 
Weighted No. 
of NFM Alert 
Overrides  
Proportion of 
NFM Alert 
Overrides 
Weighted No. 
of 
Inappropriate 
NFM Alert 
Overrides 
Frequency of 
Total 
Inappropriate 
Alert Overrides  
      


 


∗   


∗   
Oral non-formulary medications (n=80, 38.8%) 
Aprepitant (PO) 20 0 453 0.04 0.10 0.39 7.83 
60.1% (n= 123.8) 
0.00 
42.8% (n= 15.18) 
Olanzapine (PO) 20 0 1120 0.09 0.10 0.97 19.36 0.00 
Olanzapine ODT (PO) 20 1 1600 0.13 0.10 1.38 27.66 1.38 
Quetiapine (PO) 20 4 3991 0.33 0.10 3.45 68.98 13.80 
Non-oral non-formulary medications (n= 126, 61.2%) 
Dornase Alfa (Neb) 20 4 360 0.03 0.10 0.31 6.22 
39.9% (n= 82.2) 
1.24 
57.2% (n= 20.26) 
Liposomal Doxorubicin 
(IV) 6 
0 6 0.00 0.03 0.02 0.10 0.00 
Metronidazole 1% 
(Cream) 20 
6 44 0.00 0.10 0.04 0.76 0.23 
Mometasone Furoate 
(Inhaler) 20 
4 193 0.02 0.10 0.17 3.34 0.67 
Ranitidine (IV) 20 16 1127 0.09 0.10 0.97 19.48 15.58 
Rasburicase (IV) 20 0 86 0.01 0.10 0.07 1.49 0.00 
Scopolamine (Patch) 20 1 2938 0.25 0.10 2.54 50.78 2.54 
Total 206 36 11918 1.00 1.00 10.31 206 100% (n= 206) 35.4   
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Table 2: Non-Formulary Medication Alert Override Appropriateness Evaluation 
Initiate Non-Formulary Override Reason Classification
1
 
Unweighted
2
 Post-Stratification Weights Computation Weighted 
Total 
App 
Overrides 
Inapp 
Overrides 
Auxiliary 
Data 
Proportion 
of Auxiliary 
Data  
Proportion 
of Sample 
Weights Total 
App 
Overrides 
Inapp 
Overrides 
  	     


 


∗  


∗ 	 


∗  
Blank 51 31 20 446 0.216 0.248 0.873 44.54 27.07 17.46 
Disease or Condition Listed 64 60 4 682 0.331 0.311 1.064 68.10 63.84 4.26 
Home or Pre-Admission Medication 38 33 5 340 0.165 0.184 0.893 33.95 29.48 4.47 
Home Medication 38 33 5 338 0.164 0.184 0.888 33.75 29.31 4.44 
Transfer from an outside hospital 0 0 0 2 0.001 0.000 UND UND UND UND 
Marginal Value for NF Decision:  30 26 4 372 0.180 0.146 1.238 37.15 32.19 4.95 
Acknowledge NF status 2 2 0 33 0.016 0.010 1.648 3.30 3.30 0.00 
Content Free 1 1 0 9 0.004 0.005 0.899 0.90 0.90 0.00 
End of life care, Comfort measure only 0 0 0 24 0.012 0.000 UND UND UND UND 
MD/Attending/Team Request, Prefers NF 
Medication 
11 8 3 107 0.052 0.053 0.971 10.68 7.77 2.91 
MisCommunication: Medication use direction 3 3 0 14 0.007 0.015 0.466 1.40 1.40 0.00 
Others 2 2 0 29 0.014 0.010 1.448 2.90 2.90 0.00 
Patient Preference/Request 2 2 0 9 0.004 0.010 0.449 0.90 0.90 0.00 
Reason Listed "Appropriate, Effective, Indicated, 
Medical Necessity, No Alternative 
1 1 0 34 0.016 0.005 3.395 3.40 3.40 0.00 
Reason Listed "Need*/Requir* OR Patient 
Need*/Require* 
8 7 1 113 0.055 0.039 1.410 11.28 9.87 1.41 
Pharmacological Reason:  4 3 1 35 0.017 0.019 0.874 3.49 2.62 0.87 
Allergy 0 0 0 1 0.000 0.000 UND UND UND UND 
Contraindication 1 1 0 1 0.000 0.005 0.100 0.10 0.10 0.00 
Drug Route Conflict 1 0 1 24 0.012 0.005 2.397 2.40 0.00 2.40 
Drug Shortage 0 0 0 1 0.000 0.000 UND UND UND UND 
Others 2 2 0 8 0.004 0.010 0.399 0.80 0.80 0.00 
Specialist Recommendation 10 9 1 109 0.053 0.049 1.088 10.88 9.80 1.09 
Physician Specialist / Other Service 10 9 1 106 0.051 0.049 1.058 10.58 9.53 1.06 
Pharmacist 0 0 0 3 0.001 0.000 UND UND UND UND 
Therapeutic Failure / Intolerant to formulary 
alternatives:  
9 8 1 79 0.038 0.044 0.877 7.89 7.01 0.88 
Medication Listed 6 6 0 31 0.015 0.029 0.516 3.10 3.10 0.00 
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Unspecified or Medication Not Listed 3 2 1 32 0.016 0.015 1.065 3.20 2.13 1.07 
NFM effective or tolerated in the past 0 0 0 16 0.008 0.000 UND UND UND UND 
Total 206 170 36 2063 1     206 172.02 33.98 
1
Override categories that were not found in our stratified random sample, but in our auxiliary data had undefined weights, as the denominator was zero. These override reasons did not contribute 
to our analysis, but are needed for post-stratification weight computations. 
2
 Unweighted data and post-stratification weight computations are available in the online supplementary. 
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2012 NFM Alert Overrides 
N = 71,145 
Original NFM Alert 
Overrides 
N = 59,102 
NFM Alert Overrides 
N = 206ɣ 
Random selection of 20 alert overrides 
Top 11 NFMs’ 
Alert Overrides  
N = 11,918 𝟁 
Figure 3: NFM alert override random selection  
𝟁Top 11 most approved and highest costing NFMs 
ɣIn 2012 there were only six alert overrides for liposomal doxorubicin  
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